Synapsoft logo
AI Insights from Disclosures
Searching...
KOREA UNITED PHARM INC 033270
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
KOREA UNITED PHARM INC is a prescription drug manufacturer mainly selling incrementally modified drugs. Its main products include the blockbuster incrementally modified drugs 'Silostan CR Tab.', 'Atmac Combi Gel', and 'Gastiin CR Tab.', among others.
Representative Director Kang Deokyeong
Founded December 3, 1987
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 13421-0002769
Business number 307-81-05244
Phone Number 02 -516 -3041
Fax Number 02-516-2878
Website www.kup.co.kr
Company Address 25-23 Nojanggongdan-gil, Jeondong-myeon, Sejong-si
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant